HEADER APOPTOSIS 23-MAY-18 6GL8 TITLE CRYSTAL STRUCTURE OF BCL-2 IN COMPLEX WITH THE NOVEL ORALLY ACTIVE TITLE 2 INHIBITOR S55746 COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2,APOPTOSIS REGULATOR BCL-2, COMPND 3 APOPTOSIS REGULATOR BCL-2,BCL-2-LIKE PROTEIN 1,APOPTOSIS REGULATOR COMPND 4 BCL-2,APOPTOSIS REGULATOR BCL-2,APOPTOSIS REGULATOR BCL-2; COMPND 5 CHAIN: A; COMPND 6 SYNONYM: BCL2-L-1,APOPTOSIS REGULATOR BCL-X; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2, BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS KEYWDS APOPTOSIS-INHIBITOR COMPLEX, BCL-2, BH3-MIMETICS, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR P.CASARA,J.DAVIDSON,A.CLAPERON,G.LE TOUMELIN-BRAIZAT,M.VOGLER, AUTHOR 2 A.BRUNO,M.CHANRION,G.LYSIAK-AUVITY,T.LE DIGUARHER,J.B.STARCK,I.CHEN, AUTHOR 3 N.WHITEHEAD,C.GRAHAM,N.MATASSOVA,P.DOKURNO,C.PEDDER,Y.WANG,S.QIU, AUTHOR 4 A.M.GIRARD,E.SCHNEIDER,F.GRAVE,A.STUDENY,G.GUASCONI,F.ROCCHETTI, AUTHOR 5 S.MAIGA,J.M.HENLIN,F.COLLAND,L.KRAUS-BERTHIER,S.LE GOUILL, AUTHOR 6 M.J.S.DYER,R.HUBBARD,M.WOOD,M.AMIOT,G.M.COHEN,J.A.HICKMAN,E.MORRIS, AUTHOR 7 J.MURRAY,O.GENESTE REVDAT 3 17-JAN-24 6GL8 1 REMARK REVDAT 2 14-NOV-18 6GL8 1 JRNL REVDAT 1 07-NOV-18 6GL8 0 JRNL AUTH P.CASARA,J.DAVIDSON,A.CLAPERON,G.LE TOUMELIN-BRAIZAT, JRNL AUTH 2 M.VOGLER,A.BRUNO,M.CHANRION,G.LYSIAK-AUVITY,T.LE DIGUARHER, JRNL AUTH 3 J.B.STARCK,I.CHEN,N.WHITEHEAD,C.GRAHAM,N.MATASSOVA, JRNL AUTH 4 P.DOKURNO,C.PEDDER,Y.WANG,S.QIU,A.M.GIRARD,E.SCHNEIDER, JRNL AUTH 5 F.GRAVE,A.STUDENY,G.GUASCONI,F.ROCCHETTI,S.MAIGA,J.M.HENLIN, JRNL AUTH 6 F.COLLAND,L.KRAUS-BERTHIER,S.LE GOUILL,M.J.S.DYER,R.HUBBARD, JRNL AUTH 7 M.WOOD,M.AMIOT,G.M.COHEN,J.A.HICKMAN,E.MORRIS,J.MURRAY, JRNL AUTH 8 O.GENESTE JRNL TITL S55746 IS A NOVEL ORALLY ACTIVE BCL-2 SELECTIVE AND POTENT JRNL TITL 2 INHIBITOR THAT IMPAIRS HEMATOLOGICAL TUMOR GROWTH. JRNL REF ONCOTARGET V. 9 20075 2018 JRNL REFN ESSN 1949-2553 JRNL PMID 29732004 JRNL DOI 10.18632/ONCOTARGET.24744 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0222 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 26743 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1447 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.48 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3844 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 211 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1188 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 151 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.00000 REMARK 3 B22 (A**2) : -0.62000 REMARK 3 B33 (A**2) : -0.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.066 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.064 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.044 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.120 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.966 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1306 ; 0.015 ; 0.014 REMARK 3 BOND LENGTHS OTHERS (A): 1083 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1775 ; 1.820 ; 1.714 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2479 ; 1.139 ; 1.661 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 148 ; 5.360 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 86 ;29.067 ;20.465 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 203 ;16.350 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;17.262 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 148 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1507 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 271 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 582 ; 2.290 ; 2.093 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 581 ; 2.252 ; 2.085 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 726 ; 3.284 ; 3.118 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 727 ; 3.297 ; 3.122 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 724 ; 3.540 ; 2.498 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 725 ; 3.538 ; 2.497 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1044 ; 5.316 ; 3.595 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6794 ; 8.336 ;43.836 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6649 ; 8.334 ;43.446 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6GL8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200009904. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28969 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.390 REMARK 200 RESOLUTION RANGE LOW (A) : 42.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 11.5.02 REMARK 200 STARTING MODEL: 2W3L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE BUFFER PH 5.25, REMARK 280 20% JEFFAMINE600, 10% PEG3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 284K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.54500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.52000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.45000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.52000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.54500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.45000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 HIS A 2 REMARK 465 LEU A 3 REMARK 465 VAL A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 VAL A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 ASN A 39 REMARK 465 ARG A 40 REMARK 465 THR A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 PRO A 44 REMARK 465 GLU A 45 REMARK 465 GLY A 46 REMARK 465 THR A 47 REMARK 465 PRO A 204 REMARK 465 SER A 205 REMARK 465 MET A 206 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 50 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 498 O HOH A 503 1.70 REMARK 500 O HOH A 413 O HOH A 515 1.83 REMARK 500 O HOH A 436 O HOH A 515 1.91 REMARK 500 O HOH A 481 O HOH A 529 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 120 59.51 33.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 139 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F3Q A 301 DBREF 6GL8 A 9 33 UNP P10415 BCL2_HUMAN 9 33 DBREF 6GL8 A 34 50 PDB 6GL8 6GL8 34 50 DBREF 6GL8 A 92 206 UNP P10415 BCL2_HUMAN 92 206 SEQADV 6GL8 MET A -6 UNP P10415 INITIATING METHIONINE SEQADV 6GL8 HIS A -5 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A -4 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A -3 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A -2 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A -1 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A 0 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A 1 UNP P10415 EXPRESSION TAG SEQADV 6GL8 HIS A 2 UNP P10415 EXPRESSION TAG SEQADV 6GL8 LEU A 3 UNP P10415 EXPRESSION TAG SEQADV 6GL8 VAL A 4 UNP P10415 EXPRESSION TAG SEQADV 6GL8 PRO A 5 UNP P10415 EXPRESSION TAG SEQADV 6GL8 ARG A 6 UNP P10415 EXPRESSION TAG SEQADV 6GL8 GLY A 7 UNP P10415 EXPRESSION TAG SEQADV 6GL8 SER A 8 UNP P10415 EXPRESSION TAG SEQADV 6GL8 LYS A 95 UNP P10415 LEU 95 ENGINEERED MUTATION SEQADV 6GL8 GLU A 99 UNP P10415 GLN 99 ENGINEERED MUTATION SEQRES 1 A 172 MET HIS HIS HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG SEQRES 2 A 172 GLY SER TYR ASP ASN ARG GLU ILE VAL MET LYS TYR ILE SEQRES 3 A 172 HIS TYR LYS LEU SER GLN ARG GLY TYR GLU TRP ASP ALA SEQRES 4 A 172 GLY ALA ASP VAL GLU GLU ASN ARG THR GLU ALA PRO GLU SEQRES 5 A 172 GLY THR GLU SER GLU VAL VAL HIS LYS THR LEU ARG GLU SEQRES 6 A 172 ALA GLY ASP ASP PHE SER ARG ARG TYR ARG ARG ASP PHE SEQRES 7 A 172 ALA GLU MET SER SER GLN LEU HIS LEU THR PRO PHE THR SEQRES 8 A 172 ALA ARG GLY ARG PHE ALA THR VAL VAL GLU GLU LEU PHE SEQRES 9 A 172 ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SEQRES 10 A 172 GLU PHE GLY GLY VAL MET CYS VAL GLU SER VAL ASN ARG SEQRES 11 A 172 GLU MET SER PRO LEU VAL ASP ASN ILE ALA LEU TRP MET SEQRES 12 A 172 THR GLU TYR LEU ASN ARG HIS LEU HIS THR TRP ILE GLN SEQRES 13 A 172 ASP ASN GLY GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY SEQRES 14 A 172 PRO SER MET HET F3Q A 301 53 HETNAM F3Q ~{N}-(4-HYDROXYPHENYL)-3-[6-[[(3~{S})-3-(MORPHOLIN-4- HETNAM 2 F3Q YLMETHYL)-3,4-DIHYDRO-1~{H}-ISOQUINOLIN-2- HETNAM 3 F3Q YL]CARBONYL]-1,3-BENZODIOXOL-5-YL]-~{N}-PHENYL-5,6,7, HETNAM 4 F3Q 8-TETRAHYDROINDOLIZINE-1-CARBOXAMIDE FORMUL 2 F3Q C43 H42 N4 O6 FORMUL 3 HOH *151(H2 O) HELIX 1 AA1 ASP A 10 ARG A 26 1 17 HELIX 2 AA2 TRP A 30 ALA A 34 5 5 HELIX 3 AA3 SER A 49 TYR A 108 1 19 HELIX 4 AA4 TYR A 108 HIS A 120 1 13 HELIX 5 AA5 THR A 125 ARG A 139 1 15 HELIX 6 AA6 ASN A 143 ARG A 164 1 22 HELIX 7 AA7 PRO A 168 LEU A 185 1 18 HELIX 8 AA8 LEU A 185 ASN A 192 1 8 HELIX 9 AA9 GLY A 193 GLY A 203 1 11 SITE 1 AC1 18 PHE A 104 TYR A 108 ASP A 111 PHE A 112 SITE 2 AC1 18 GLN A 118 LEU A 137 GLY A 145 ARG A 146 SITE 3 AC1 18 ALA A 149 PHE A 153 ASP A 171 HOH A 415 SITE 4 AC1 18 HOH A 421 HOH A 431 HOH A 482 HOH A 484 SITE 5 AC1 18 HOH A 489 HOH A 525 CRYST1 35.090 46.900 85.040 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028498 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021322 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011759 0.00000